Eisenberg R M, Johnson C
Department of Pharmacology, University of Minnesota, Duluth School of Medicine 55812.
Life Sci. 1989;44(20):1457-66. doi: 10.1016/0024-3205(89)90324-x.
Diazepam has been shown to produce physical dependence based on observations of behavioral stimulation or, in our laboratory, by increases in plasma corticosterone (CS) during antagonist-precipitated withdrawal. The behavioral excitation appears similar to that observed following the administration of beta-carboline esters--agents reported to interact with benzodiazepine receptors and termed "inverse agonists." The focus of the present study is to correlate the occurrence of changes in CS with behavioral excitation previously observed by others. Further, these studies are designed to show a parallel between the manifestations of benzodiazepine withdrawal and the pharmacologic effects of beta-carboline ethyl ester. Experiments were done in conscious unrestrained male Sprague-Dawley rats, with chronic i.v. catheters, using sound-attenuated one-way vision boxes. These studies compared the hormonal and behavioral changes induced by beta-carboline ethyl ester (beta CCE) with CGS-8216-precipitated withdrawal in rats treated with diazepam for 8 days. Rats treated chronically with diazepam (5 mg/kg/day), showed a significant increase in plasma (CS) following CGS-8216. Behavioral abstinence scores were also significantly elevated. beta CCE (0.5-5.0 mg/kg) showed a significant dose-related increase in plasma CS. Behavioral scores were also increased at doses of 0.5 and 2.0 mg/kg. beta CCE-induced plasma CS increases were antagonized by CGS-8216 at doses of 1.0 and 2.0 mg/kg but not by 0.5 mg/kg. In animals chronically treated with diazepam, beta CCE evoked a more prolonged plasma CS elevation than in vehicle-treated animals suggesting a dual agonist/antagonist effect. These data suggest a parallel between CS elevations and behavioral effects during withdrawal as well as similarities between the action of beta CCE and the manifestations of this withdrawal.
基于行为刺激的观察结果,或在我们实验室中通过拮抗剂诱发戒断期间血浆皮质酮(CS)升高的现象,已表明地西泮会产生身体依赖性。行为兴奋与给予β-咔啉酯后观察到的情况相似——据报道,β-咔啉酯类药物与苯二氮䓬受体相互作用,被称为“反向激动剂”。本研究的重点是将CS变化的发生与其他人先前观察到的行为兴奋联系起来。此外,这些研究旨在表明苯二氮䓬戒断的表现与β-咔啉乙酯的药理作用之间的平行关系。实验在清醒不受约束的雄性Sprague-Dawley大鼠身上进行,使用慢性静脉导管,并置于隔音的单向观察箱中。这些研究比较了β-咔啉乙酯(βCCE)与CGS-8216诱发的戒断所引起的激素和行为变化,实验对象为用安定治疗8天的大鼠。长期用安定(5毫克/千克/天)治疗的大鼠,在给予CGS-8216后,血浆(CS)显著升高。行为戒断评分也显著升高。βCCE(0.5 - 5.0毫克/千克)显示血浆CS随剂量显著增加。在0.5和2.0毫克/千克剂量时,行为评分也增加。1.0和2.0毫克/千克剂量的CGS-8216可拮抗βCCE诱导的血浆CS升高,但0.5毫克/千克剂量则不能。在长期用安定治疗的动物中,βCCE诱发的血浆CS升高比用赋形剂治疗的动物更持久,提示具有双重激动剂/拮抗剂作用。这些数据表明,戒断期间CS升高与行为效应之间存在平行关系,以及βCCE的作用与这种戒断表现之间存在相似性。